Vanguard Group Inc Soma Logic, Inc. Transaction History

Vanguard Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $328,160 - $527,667	186,455 Added 2.36%	8,102,144 $20.5 Million
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $165,446 - $203,690	83,139 Added 1.06%	7,915,689 $18.9 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $214,918 - $343,869	102,342 Added 1.32%	7,832,550 $18.1 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $227,128 - $383,878	106,633 Added 1.4%	7,730,208 $19.7 Million
Q4 2022 Feb 10, 2023	BUY	$2.05 - $3.47 $188,228 - $318,611	91,819 Added 1.22%	7,623,575 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $112,942 - $980,628	179,274 Added 2.44%	7,531,756 $21.8 Million
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $3.75 Million - $7.26 Million	878,592 Added 13.57%	7,352,482 $33.2 Million
Q1 2022 May 13, 2022	BUY	$7.07 - $11.62 $28 Million - $46.1 Million	3,965,138 Added 158.05%	6,473,890 $51.9 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $19.3 Million - $26.3 Million	1,844,007 Added 277.4%	2,508,752 $29.2 Million
Q3 2021 Nov 12, 2021	BUY	$9.94 - $12.77 $6.61 Million - $8.49 Million	664,745 New	664,745 $8.24 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.